The age-specific comorbidity burden of mild cognitive impairment: a US claims database study
This is my archive
Expected wait times for access to a disease-modifying Alzheimer’s treatment in England: A modelling study
Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population
Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
A Literature Review on the Burden of Alzheimer’s Disease on Care Partners
Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
Preparedness of China’s health care system to provide access to a disease-modifying Alzheimer’s treatment
Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care
